$481 Million is the total value of Essex Woodlands Management, Inc.'s 10 reported holdings in Q3 2016. The portfolio turnover from Q2 2016 to Q3 2016 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ABMD | ABIOMED INC | $186,441,000 | +17.6% | 1,450,000 | 0.0% | 38.79% | -2.8% | |
| ENTL | ENTELLUS MED INC | $84,577,000 | +21.4% | 3,813,197 | 0.0% | 17.60% | +0.3% | |
| RVNC | REVANCE THERAPEUTICS INC | $74,437,000 | +19.2% | 4,592,047 | 0.0% | 15.49% | -1.6% | |
| CORI | CORIUM INTL INC | $52,659,000 | +62.2% | 9,353,304 | 0.0% | 10.96% | +34.0% | |
| AXGN | AXOGEN INC | $43,896,000 | +31.3% | 4,861,111 | 0.0% | 9.13% | +8.4% | |
| ELGX | ENDOLOGIX INC | $22,855,000 | +3.1% | 1,257,468 | 0.0% | 4.76% | -14.9% | |
| MNOV | MEDICINOVA INC | $8,766,000 | -0.8% | 1,170,370 | 0.0% | 1.82% | -18.1% | |
| ACUR | ACURA PHARMACEUTICALS INC | $3,130,000 | -13.5% | 1,956,397 | 0.0% | 0.65% | -28.6% | |
| LGND | LIGAND PHARMACEUTICALS INC | $2,400,000 | -38.8% | 32,893 | 0.0% | 0.50% | -49.5% | |
| CBIO | CATALYST BIOSCIENCES INC | $1,448,000 | -20.6% | 1,179,352 | 0.0% | 0.30% | -34.6% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MEDICINOVA INC | 42 | Q3 2023 | 6.5% |
| REVANCE THERAPEUTICS INC | 39 | Q3 2023 | 44.6% |
| AXOGEN INC | 26 | Q4 2021 | 43.3% |
| ENDOLOGIX INC | 24 | Q1 2019 | 22.5% |
| ABIOMED INC | 20 | Q1 2018 | 52.1% |
| CORIUM INTL INC | 20 | Q1 2019 | 23.5% |
| TELA BIO, INC. | 16 | Q3 2023 | 31.5% |
| VENUS CONCEPT, INC. | 16 | Q3 2023 | 21.3% |
| ACURA PHARMACEUTICALS INC | 15 | Q1 2019 | 1.4% |
| CATALYST BIOSCIENCES INC | 15 | Q1 2019 | 1.0% |
View Essex Woodlands Management, Inc.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View Essex Woodlands Management, Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.